Table 1.

Baseline characteristics of the sample under study

		Benign	Borderline	Malignant
Number	n(%)	120 (77.4)	8 (5.2)	27 (17.4)
Age (years)	Median (range)	38 (14–78)	37.5 (24–61)	52 (23–72)
Postmenopausal status	n(%)	21 (17.5)	2 (25)	19 (70.4)
RMI1	Median (range)	18.03 (0–1679)	23.06 (0–156)	340.80 (0–19,224)
RMI2	Median (range)	35.94 (4.15–1679)	57.48 (11.07–277.92)	454.4 (12.67–34,176)
RMI3	Median (range)	31.65 (4.15–1679)	48.49 (11.07–158.4)	340.8 (12.67–19,224)
RMI4	Median (range)	52.02 (4.15–3358)	77.80 (11.07–555.84)	908.80 (12.67–68,352)
ROMA	Median (range)	5.9 (1.6–28.5)	8.2 (3.2–60.9)	34.6 (4–99.1)
HE4 pmol/l	Median (range)	42.17 (25.37–123)	47.03 (34.47–163.30)	57.59 (35.57- > 1500)

RMI Risk of malignancy index, ROMA Risk Of Malignancy Algorithm, HE4 Human Epididymis Protein 4